Paper Details

  1. Home
  2. Paper Details

Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C.

Author: AraseY, ChayamaK, IkedaK, KobayashiM, KumadaH, MatsumotoT, MorinagaT, SaitohS, SakaiY, UnakamiM

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Interferon treatment for chronic hepatitis C resulted in undetectable hepatitis C virus RNA levels in 13 out of 16 patients. Five patients remained RNA-negative after 6 months, with histological improvement. Interferon should be considered for patients who become RNA-negative during treatment but test positive again after stopping therapy.
Paper Details　
Original Abstract of the Article :
Hepatitis C virus RNA as detected by reverse transcription and nested polymerase chain reaction was monitored in 16 patients with chronic hepatitis C treated with interferon. Hepatitis C virus RNA became undetectable after 4 to 8 wk of interferon administration in 13 of the 16 patients. During 6 mo ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/1711001

データ提供：米国国立医学図書館（NLM）

Interferon's Impact on Hepatitis C Virus RNA

In the vast and unforgiving landscape of viral infections, hepatitis C presents a significant challenge. This study delves into the effects of interferon administration on serum hepatitis C virus (HCV) RNA levels in patients with chronic hepatitis C. The authors monitored HCV RNA levels in 16 patients using a sophisticated technique called reverse transcription and nested polymerase chain reaction. They discovered that HCV RNA became undetectable in 13 of the 16 patients after 4 to 8 weeks of interferon treatment. However, the study also found that HCV RNA levels returned to detectable levels in 8 of the 13 patients after the treatment was stopped, suggesting that interferon alone may not be a long-term solution for all patients. Nevertheless, the study highlights the potential of interferon as a treatment option, particularly in the early stages of chronic hepatitis C.

Interferon: A Temporary Oasis in the Hepatitis C Desert?

The study's findings suggest that interferon administration can temporarily suppress HCV RNA levels in a significant proportion of patients with chronic hepatitis C. While interferon may not be a permanent solution for all patients, it offers a potential avenue for management and control. The study highlights the need for ongoing research to develop more durable and effective treatment strategies for hepatitis C.

Staying Hydrated in the Hepatitis C Desert

If you have been diagnosed with hepatitis C, it's essential to consult with a healthcare professional to discuss treatment options and ensure you receive proper care. The study's findings underscore the importance of ongoing research in developing effective treatment strategies for this challenging viral infection.

Dr.Camel's Conclusion

This study sheds light on the potential of interferon in treating chronic hepatitis C. While the effects may be temporary, it provides a glimmer of hope in the vast and sometimes unforgiving landscape of this viral infection. It's crucial to continue exploring alternative approaches and developing more comprehensive treatment strategies for those facing this health challenge.

Date :
  1. Date Completed 1991-07-23
  2. Date Revised 2004-11-17
Further Info :

Pubmed ID

1711001

DOI: Digital Object Identifier

S0270913991001350

Related Literature

Article Analysis
・Effective treatment of hepatitis c
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.